Overview

Timing of VTE Prophylaxis in TBI

Status:
Withdrawn

Trial end date:
2019-08-12

Target enrollment:

Participant gender:

Summary

This study compares the efficacy and complication rates of early (24 hours) versus late (72 hours) VTE prophylaxis administration to TBI patients. Patients in both treatment groups will be monitored for development of VTE as well as complications from bleeding after commencement of VTE prophylaxis.

Phase:

Phase 4

Details

Lead Sponsor:

Loyola University

Treatments:

Calcium heparin
Enoxaparin
Enoxaparin sodium
Heparin